Unknown

Dataset Information

Predicting Direct-Specimen SARS-CoV-2 Assay Performance Using Residual Patient Samples.


ABSTRACT:

Background

Diagnostic sensitivities of point-of-care SARS-CoV-2 assays depend on specimen type and population-specific viral loads. Evaluation of these assays require "direct" specimens from paired-swab studies rather than more accessible residual specimens in viral transport media (VTM).

Methods

Residual VTM and limit-of-detection studies were conducted on Abbott ID NOW™ COVID-19, Quidel Sofia 2™ SARS Antigen FIA, and DiaSorin Simplexa™ COVID-19 Direct assays, with cycle threshold (CT) adjustments to approximate direct-specimen testing based on gene-target doubling each PCR cycle. Logistic regression was used to model assay performance by specimen CT. These models were applied to CT distributions of symptomatic and asymptomatic populations presenting to emergency services t

SUBMITTER: Schroeder LF 

PROVIDER: S-EPMC8767897 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature